Charalampos Aslanidis

10.0k citations

119 papers · 7.2k indexed · 2 hit papers · h-index 42

Molecular Biology top 2%
Surgery top 1%
Epidemiology top 2%
Oncology top 2%
Physiology top 2%

Co-authors: Pieter J. de Jong Gerd Schmitz Christa Buechler Andréas Schäffler Thomas Langmann Markus Neumeier Johanna Weigert Christa Büchler
Topics: Adipokines, Inflammation, and Metabolic Diseases (25 papers)Cholesterol and Lipid Metabolism (17 papers)Adipose Tissue and Metabolism (13 papers)
Cited by: Biochemistry Molecular Biology Epidemiology
Journals: Nature Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: Germany United States Switzerland

In The Last Decade

Charalampos Aslanidis

118 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

1999 1.3k citations Evelyn Orsó, Thomas Langmann et al. profile →
Ligation-independent cloning of PCR products (LIC-PCR)

1990 961 citations Charalampos Aslanidis, Pieter J. de Jong Nucleic Acids Research profile →

Peers

Countries citing papers authored by Charalampos Aslanidis

Since Specialization

Citations

This map shows the geographic impact of Charalampos Aslanidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charalampos Aslanidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charalampos Aslanidis more than expected).

Fields of papers citing papers by Charalampos Aslanidis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charalampos Aslanidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charalampos Aslanidis. The network helps show where Charalampos Aslanidis may publish in the future.

Co-authorship network of co-authors of Charalampos Aslanidis

This figure shows the co-authorship network connecting the top 25 collaborators of Charalampos Aslanidis. A scholar is included among the top collaborators of Charalampos Aslanidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charalampos Aslanidis. Charalampos Aslanidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels are not associated with severity of liver disease and are inversely related to cholesterol in a cohort of thirty eight patients with liver cirrhosis 2021 ·Lipids in Health and Disease ·(unknown),Reiner Wiest,Thomas S. Weiß,Charalampos Aslanidis,Doris Schacherer,Sabrina Krautbauer,Gerhard Liebisch,Christa Buechler	15
2	Free Fatty Acids, Lipopolysaccharide and IL-1α Induce Adipocyte Manganese Superoxide Dismutase Which Is Increased in Visceral Adipose Tissues of Obese Rodents 2014 ·PLoS ONE ·Sabrina Krautbauer,Kristina Eisinger,Markus Neumeier,(unknown),Roland Buettner,Peter Schmid,Charalampos Aslanidis,Christa Buechler	21
3	LDL but not HDL increases adiponectin release of primary human adipocytes 2013 ·Experimental and Molecular Pathology ·Sabrina Krautbauer,Markus Neumeier,Kristina Eisinger,(unknown),Ashraf Dada,Gerd Schmitz,Charalampos Aslanidis,Christa Buechler	8
4	Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes 2010 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Josef Wanninger,Markus Neumeier,Claus Hellerbrand,Doris Schacherer,Sabrina Bauer,Thomas S. Weiß,Hanna Huber,Andréas Schäffler,Charalampos Aslanidis,Jürgen Schölmerich,Christa Buechler	40
5	Association of HDL Deficiency with a Novel Mutation in the ABCA1 Gene 2010 ·Experimental and Clinical Endocrinology & Diabetes ·Gerald Denk,Charalampos Aslanidis,G. Schmitz,Klaus G. Parhofer,Thomas Pusl	2
6	Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohnʼs disease 2009 ·Inflammatory Bowel Diseases ·Johanna Weigert,Florian Obermeier,Markus Neumeier,Josef Wanninger,Michael Filarsky,Sabrina Bauer,Charalampos Aslanidis,Gerhard Rogler,Claudia Ott,Andréas Schäffler,Jürgen Schölmerich,Christa Buechler	135
7	Skoura – a genetic island for congenital insensitivity to pain and anhidrosis among Moroccan Jews, as determined by a novel mutation in the NTRK1 gene 2009 ·Clinical Genetics ·(unknown),Morad Khayat,Markus Weiler,Nehama Cohen Kfir,Cindy Cohen,(unknown),Charalampos Aslanidis,Gerd Schmitz,(unknown)	11
8	Effects of the new adiponectin paralogous protein CTRP-3 and of LPS on cytokine release from monocytes of patients with type 2 diabetes mellitus 2009 ·Cytokine ·Andrea Kopp,Margarita Bala,Johanna Weigert,Christa Büchler,Markus Neumeier,Charalampos Aslanidis,Jürgen Schölmerich,Andréas Schäffler	56
9	Insulin induces monocytic CXCL8 secretion by the mitogenic signalling pathway 2008 ·Cytokine ·(unknown),Markus Neumeier,Johanna Weigert,Josef Wanninger,(unknown),(unknown),Andréas Schäffler,Charalampos Aslanidis,Jürgen Schölmerich,Christa Buechler	9
10	Alteration of the Pulmonary Surfactant System in Full-Term Infants with Hereditary ABCA3 Deficiency 2006 ·American Journal of Respiratory and Critical Care Medicine ·Frank Brasch,Sven Schimanski,Christian Mühlfeld,Stefan Barlage,Thomas Langmann,Charalampos Aslanidis,Alfred Boettcher,Ashraf Dada,Horst Schroten,Eva Mildenberger,(unknown),Manfred Ballmann,Matthias Ochs,Georg Johnen,Matthias Griese,Gerd Schmitz	109
11	Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes 2006 ·Cardiovascular Diabetology ·(unknown),Markus Neumeier,Johanna Weigert,(unknown),Elke Eggenhofer,Andréas Schäffler,(unknown),Charalampos Aslanidis,Jürgen Schölmerich,Christa Buechler	47
12	High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes 2006 ·Biochemical and Biophysical Research Communications ·Markus Neumeier,Alexander Sigrüener,Elke Eggenhofer,Johanna Weigert,Thomas S. Weiß,Andreas Schaeffler,Hans J. Schlitt,Charalampos Aslanidis,Pompiliu Piso,Thomas Langmann,Gerd Schmitz,Jürgen Schölmerich,Christa Buechler	50
13	Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease 2006 ·Journal of Molecular Medicine ·Christoph Moehle,Nikolaus Ackermann,Thomas Langmann,Charalampos Aslanidis,Alexander Kel,Olga Kel‐Margoulis,(unknown),Alexandra Zahn,Wolfgang Stremmel,Gerd Schmitz	132
14	Influence of interleukin‐1 gene polymorphism on periodontal regeneration in intrabony defects 2003 ·Journal of Periodontal Research ·M. Christgau,Charalampos Aslanidis,(unknown),Karl‐Anton Hiller,Gerd Schmitz,Gottfried Schmalz	15
15	Structural organization and characterization of the promoter region of a human carboxylesterase gene 1997 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Thomas Langmann,(unknown),Charalampos Aslanidis,Frank Notka,Heidrun Ullrich,(unknown),Gerd Schmitz	37
16	Isolation and Characterization of a 14.5‐kDa Trichloroacetic‐Acid‐Soluble Translational Inhibitor Protein from Human Monocytes that is Upregulated Upon Cellular Differentiation 1996 ·European Journal of Biochemistry ·(unknown),Claus Kerkhoff,Evelyn Orsó,Josef Stöhr,Charalampos Aslanidis,György M. Nagy,Ruth Knuechel,Gerd Schmitz	78
17	Genetic and Biochemical Evidence That CESD and Wolman Disease Are Distinguished by Residual Lysosomal Acid Lipase Activity 1996 ·Genomics ·Charalampos Aslanidis,Stefan Ries,(unknown),Christa Büchler,(unknown),Gerd Schmitz	114
18	Minimal length requirement of the single-stranded tails for ligation-independent cloning (LIC) of PCR products. 1994 ·Genome Research ·Charalampos Aslanidis,Pieter J. de Jong,Gerd Schmitz	50
19	A two-dimensional YAC pooling strategy for library screeningviaSTS andAlu-PCR methods 1992 ·Nucleic Acids Research ·Chris T. Amemiya,Michelle Alegria-Hartman,Charalampos Aslanidis,(unknown),Julia Nikolic,Jeffrey C. Gingrich,Pieter J. de Jong	19
20	Ligation-independent cloning of PCR products (LIC-PCR)breakdown → 1990 ·Nucleic Acids Research ·Charalampos Aslanidis,Pieter J. de Jong	961

About Charalampos Aslanidis

Charalampos Aslanidis is a scholar working on Physiology, Biochemistry and Physiology, having authored 119 papers that have together received 7.2k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (25 papers), Cholesterol and Lipid Metabolism (17 papers) and Adipose Tissue and Metabolism (13 papers). The work is most often cited by research in Biochemistry (379 citations), Molecular Biology (3.6k citations) and Epidemiology (1.6k citations). Charalampos Aslanidis has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Pieter J. de Jong, Gerd Schmitz, Christa Buechler, Andréas Schäffler, Thomas Langmann, Markus Neumeier, Johanna Weigert, Christa Büchler, Karl J. Lackner and Jürgen Schölmerich. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact